<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A7D96C1B-22B7-4E02-9683-66C2D5BE9549"><gtr:id>A7D96C1B-22B7-4E02-9683-66C2D5BE9549</gtr:id><gtr:name>Ningbo Number One Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/8F824B8F-8C09-4001-9938-361704339A85"><gtr:id>8F824B8F-8C09-4001-9938-361704339A85</gtr:id><gtr:name>Kathmandu University</gtr:name><gtr:address><gtr:line1>P. O. Box: 6250</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>School of Medicine</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A7D96C1B-22B7-4E02-9683-66C2D5BE9549"><gtr:id>A7D96C1B-22B7-4E02-9683-66C2D5BE9549</gtr:id><gtr:name>Ningbo Number One Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/8F824B8F-8C09-4001-9938-361704339A85"><gtr:id>8F824B8F-8C09-4001-9938-361704339A85</gtr:id><gtr:name>Kathmandu University</gtr:name><gtr:address><gtr:line1>P. O. Box: 6250</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B6B6213D-3EDE-4C40-A6BE-6E8F2CB9048A"><gtr:id>B6B6213D-3EDE-4C40-A6BE-6E8F2CB9048A</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Hall</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/737D64F9-E64B-425C-9770-408222FAC8AE"><gtr:id>737D64F9-E64B-425C-9770-408222FAC8AE</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Sayers</gtr:surname><gtr:orcidId>0000-0001-5601-5410</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6C92C852-396C-4DC4-9339-91AD1A4BA8AD"><gtr:id>6C92C852-396C-4DC4-9339-91AD1A4BA8AD</gtr:id><gtr:firstName>Martin</gtr:firstName><gtr:surname>Tobin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G1000861"><gtr:id>863B43C5-57ED-4EFD-9918-CB343315ACA3</gtr:id><gtr:title>Defining the genetic contribution and functional role to altered lung function of genes identified by GWAS meta-analysis</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1000861</gtr:grantReference><gtr:abstractText>Chronic obstructive pulmonary disease (COPD) is a common cause of illness, occuring mostly in smokers, which results in worsening cough and breathlessness and which is responsible for 30,000 deaths per year in the UK. It is recognised that genetics plays a role in the development of COPD, and recently we have identified that genetic variants in three genes called glutathione S transferase CD (GSTCD), HTR4 and AGER are risk factors for the development of abnormal lung function and COPD. The aims of this programme of research are to find out the role of these genes in the lungs, to determine how genetic variability in these genes alters lung function, and to assess how different genetic variants contribute to the development of airways disease focusing initially on COPD.</gtr:abstractText><gtr:technicalSummary>We have recently identified GSTCD, AGER and HTR4 as key genetic factors which in part determine lung function and risk of COPD at the population level. Little is known regarding the function of GSTCD, although homology searches suggest it may act either as a regulator of GST activity, a modifier of Ca2+ signalling, or as a regulator of Cl- homeostasis. The role of HTR4 in determining airway function is also unclear although it may modify either cholinergic neurotransmission or potentially epithelial function. AGER is known to be a marker of epithelial injury in the lungs, but characterisation of functional variants has not been performed to date. The key hypothesis underlying this proposal is that functional variants in genes identified by genome wide association study are an important determinant of FEV1 in both the general population and in patients with respiratory diseases such as COPD.
In order to address this hypothesis the programme has four main aims: (i) to determine the key genetic variants in these 3 genes, (ii)to define the functional role for these genes in relevant airway and inflammatory cells, (iii) to identify key functional variants of GSTCD, AGER and HTR4 and (iv) to determine the contribution of variants in these genes to lung function in the general population and subjects with COPD and asthma.</gtr:technicalSummary><gtr:fund><gtr:end>2017-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1326304</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Joint studentship on lung development</gtr:description><gtr:id>2BF72551-802E-4E48-9515-9AECEE6A6F3D</gtr:id><gtr:impact>none at present</gtr:impact><gtr:partnerContribution>Access to laboratory faciliites, expertise, access to mice from the International Mouse Consortium</gtr:partnerContribution><gtr:piContribution>Joint studentship to explore functinal genetics (UoN) and developmental biology (ICL)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Kathmandu University</gtr:collaboratingOrganisation><gtr:country>Nepal, State of</gtr:country><gtr:description>Kathmandu University</gtr:description><gtr:id>1EADEE6D-D120-4AE4-BEFA-DE14E93822A9</gtr:id><gtr:impact>Grant form Association of Physicians developing countries links programme.
This is a multidisciplinary award involving medicine, engineering, social sceince and architecture/built environment partners</gtr:impact><gtr:partnerContribution>Salary and local support for student whilst in Nepal, provision of samples from Nepal</gtr:partnerContribution><gtr:piContribution>Host laboratory for visiting PhD student from engineering faculty working on impact of low emission stove systems in COPD</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ningbo Number One Hospital</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>Ningbo hospitals</gtr:description><gtr:id>3DC9610B-A368-44D8-B071-3983171F6F54</gtr:id><gtr:impact>formal agreement with Ningbo number 1 hospital and planned additional academic exchanges</gtr:impact><gtr:partnerContribution>Salary, travel and living costs for visiting fellow</gtr:partnerContribution><gtr:piContribution>Provision of laboratory facilities for visiting scholar during 2015 for 12 months to study molecular genetics of lung function associated genes</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>follow on studies on functional genetics</gtr:description><gtr:id>86BE55A1-9B72-4008-85AB-58F3FCC255AA</gtr:id><gtr:impact>none to date</gtr:impact><gtr:partnerContribution>provision of materials/compounds/funding</gtr:partnerContribution><gtr:piContribution>laboratory studies, ex vivo human studies</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Royal Society science week</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>30CCCC80-2FEF-4D7F-8D42-3DDFC9600656</gtr:id><gtr:impact>contribution to stand at royal society science exhibition summer 2012 (main presenter Martin Tobin) based on respiratory genetics

&amp;gt;2000 visitors over the week</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NG paper 2017 media</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>699448B0-FB2E-49A2-991E-35A4459FFF94</gtr:id><gtr:impact>Press release and consequent media interviews including TV and radio interviews</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>uk biobank meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>46108512-DFE4-4EA8-93DC-4EED03EEF865</gtr:id><gtr:impact>UK Biobank workshop, Houses of Parliament</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK biobank regional event</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>85983EC9-CA0E-4DCE-A926-781CBA9FAA04</gtr:id><gtr:impact>Talk to UK Biobank regional event for research participants</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Media interviews</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9C774955-E3B2-4CAE-81ED-A45858F37D4F</gtr:id><gtr:impact>Series of interviews following publication of Lancet Resp Med paper on UK biobank, coupled with media releases from MRC and Univeristy of Nottingham. Interviews included multiple local radio stations, Today programme, ABC News 24, San Francisco Bay radio and others</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>9000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Association of Physicians links in developing countries award</gtr:description><gtr:fundingOrg>Association of Physicians of Great Britain and Ireland</gtr:fundingOrg><gtr:id>EC5201DC-F569-46A7-91DB-3979DF10B25E</gtr:id><gtr:sector>Learned Society</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>23600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR/BRC</gtr:department><gtr:description>Nottingham BRC</gtr:description><gtr:end>2022-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research (NIHR)</gtr:fundingOrg><gtr:id>881E95C6-0EFA-4DFC-927E-C95625B9384C</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>540000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pfizer internal funds</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Pfizer Ltd</gtr:fundingOrg><gtr:id>194DB044-3C31-4AFE-AC04-F61C68373031</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>180000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Boehringer Ingelheim</gtr:department><gtr:description>industry collaboration,</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>C.H. Boehringer Sohn AG &amp; Ko. KG</gtr:fundingOrg><gtr:id>22A6FA19-712D-408B-9B98-72A2BE588419</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2016-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>400000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pfizer internal funds</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Pfizer Inc</gtr:fundingOrg><gtr:id>C8CD5A56-5762-4A50-B55E-A39304F46BCD</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Chiesi foundation</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Chiesi</gtr:fundingOrg><gtr:id>F9A2C75E-9A86-4F0A-90F4-9EDF5CA2E0BD</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2013-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3240000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC strategic award</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>D6B23B96-EE8B-485A-9E0E-9A36C7AD69D9</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>As above: provosion of genotype data on 50,000 individuals in UK biobank</gtr:description><gtr:id>A731A94D-E570-4A3B-BDF3-CE4F77C510C8</gtr:id><gtr:impact>Publications in preparation.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Genotype data for UK Biobank</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Genetic data from combined Spirometa and CHARGE meta analyses, plus 1000 genomes imputed data from Spirometa</gtr:description><gtr:id>0E60ADC0-9936-4160-8B2B-0B5EF1DE9879</gtr:id><gtr:impact>contribution to publications, look ups for other research groups</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Genotype data from Spirometa studies</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>association values for lung function SNPs from joint SPIROMETA/CHARGE analyses</gtr:description><gtr:id>CF1C2375-C369-43C0-BB85-1841A9FE740D</gtr:id><gtr:impact>provides open access to GWAS dataset</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>GWAS lung function dataset</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C047F48C-5C90-4F41-9641-D3B102A27707"><gtr:id>C047F48C-5C90-4F41-9641-D3B102A27707</gtr:id><gtr:title>Cigarette Smoke and the Induction of Urokinase Plasminogen Activator Receptor In Vivo: Selective Contribution of Isoforms to Bronchial Epithelial Phenotype.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3caae8bb41bad3529bd1a928096e4f76"><gtr:id>3caae8bb41bad3529bd1a928096e4f76</gtr:id><gtr:otherNames>Portelli MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1044-1549</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/660F6C77-E5B8-44EA-B27F-A2BC5BE8D4DD"><gtr:id>660F6C77-E5B8-44EA-B27F-A2BC5BE8D4DD</gtr:id><gtr:title>Sixteen new lung function signals identified through 1000 Genomes Project reference panel imputation.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/346132cc73b072383cbff8aaa61b0286"><gtr:id>346132cc73b072383cbff8aaa61b0286</gtr:id><gtr:otherNames>Soler Artigas M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2D5EB204-2427-48B9-9F4D-45EE7DDD7523"><gtr:id>2D5EB204-2427-48B9-9F4D-45EE7DDD7523</gtr:id><gtr:title>Genome-wide association analysis identifies six new loci associated with forced vital capacity.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/709f22fc76ef5afc571a9a040d0788d6"><gtr:id>709f22fc76ef5afc571a9a040d0788d6</gtr:id><gtr:otherNames>Loth DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6A29F95E-87BC-4593-AC67-3756772AFB5A"><gtr:id>6A29F95E-87BC-4593-AC67-3756772AFB5A</gtr:id><gtr:title>Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a94bd817e0697ab1ede1ac552afec188"><gtr:id>a94bd817e0697ab1ede1ac552afec188</gtr:id><gtr:otherNames>Wain LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8AF41130-E6E9-4358-84D1-2FD8F566DD11"><gtr:id>8AF41130-E6E9-4358-84D1-2FD8F566DD11</gtr:id><gtr:title>Effects of atopy and grass pollen season on histamine H4 receptor expression in human leukocytes.</gtr:title><gtr:parentPublicationTitle>Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fe32325bae48796adae9123bd72921c5"><gtr:id>fe32325bae48796adae9123bd72921c5</gtr:id><gtr:otherNames>Hodge E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1081-1206</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4A5170E6-789B-4748-AFA4-0A2E216E0B57"><gtr:id>4A5170E6-789B-4748-AFA4-0A2E216E0B57</gtr:id><gtr:title>Large-scale genome-wide association studies and meta-analyses of longitudinal change in adult lung function.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2b075caf9f3c926cd0e0e2f0cecad19b"><gtr:id>2b075caf9f3c926cd0e0e2f0cecad19b</gtr:id><gtr:otherNames>Tang W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9FDCCAC5-1990-4213-845F-3BD3AED92D69"><gtr:id>9FDCCAC5-1990-4213-845F-3BD3AED92D69</gtr:id><gtr:title>Should we use ADRB2 variation to stratify asthma treatment?</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/022db3eaa432db2d50da8b60d7b7a194"><gtr:id>022db3eaa432db2d50da8b60d7b7a194</gtr:id><gtr:otherNames>Hall IP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BA22E283-7992-4E4F-A623-21BACB24D25F"><gtr:id>BA22E283-7992-4E4F-A623-21BACB24D25F</gtr:id><gtr:title>Genes associated with polymorphic variants predicting lung function are differentially expressed during human lung development.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/773f51694c81fa0805c69c6e23f77df1"><gtr:id>773f51694c81fa0805c69c6e23f77df1</gtr:id><gtr:otherNames>Miller S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FADC42B8-2C02-4F87-A2FB-8225B56565DE"><gtr:id>FADC42B8-2C02-4F87-A2FB-8225B56565DE</gtr:id><gtr:title>Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6d5dcc4dec7a05ce5d6eaf7620dc466c"><gtr:id>6d5dcc4dec7a05ce5d6eaf7620dc466c</gtr:id><gtr:otherNames>Hancock DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DA770C03-066F-423C-B827-34D526CB8A21"><gtr:id>DA770C03-066F-423C-B827-34D526CB8A21</gtr:id><gtr:title>Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/55ea5e8e0701a4bf9fd4b547fc5695b7"><gtr:id>55ea5e8e0701a4bf9fd4b547fc5695b7</gtr:id><gtr:otherNames>Wilk JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/06EA2870-2F34-4548-BD22-994FA1C8451F"><gtr:id>06EA2870-2F34-4548-BD22-994FA1C8451F</gtr:id><gtr:title>Integrative pathway genomics of lung function and airflow obstruction.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9c05559d7335b9b762af57cf666e411c"><gtr:id>9c05559d7335b9b762af57cf666e411c</gtr:id><gtr:otherNames>Gharib SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E555CF20-FF22-4EDE-9FF6-775994B7D55E"><gtr:id>E555CF20-FF22-4EDE-9FF6-775994B7D55E</gtr:id><gtr:title>Molecular mechanisms underlying variations in lung function: a systems genetics analysis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/50b8ae389974a10a5749dc28b02da493"><gtr:id>50b8ae389974a10a5749dc28b02da493</gtr:id><gtr:otherNames>Obeidat M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F32D9C27-A2DA-4361-8EF4-67633BF6F5B6"><gtr:id>F32D9C27-A2DA-4361-8EF4-67633BF6F5B6</gtr:id><gtr:title>The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/773f51694c81fa0805c69c6e23f77df1"><gtr:id>773f51694c81fa0805c69c6e23f77df1</gtr:id><gtr:otherNames>Miller S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/634C9FF5-37B4-40E6-BA44-6074774D917F"><gtr:id>634C9FF5-37B4-40E6-BA44-6074774D917F</gtr:id><gtr:title>Use of FEV1 as a measure of lung health in the UK BiLEVE study - Authors' reply.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a94bd817e0697ab1ede1ac552afec188"><gtr:id>a94bd817e0697ab1ede1ac552afec188</gtr:id><gtr:otherNames>Wain LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E8E16300-E953-4022-BFCB-946BBA9FE692"><gtr:id>E8E16300-E953-4022-BFCB-946BBA9FE692</gtr:id><gtr:title>Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c59643f868fe45e6543f1860f389469b"><gtr:id>c59643f868fe45e6543f1860f389469b</gtr:id><gtr:otherNames>Thun GA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8AE944A8-77A6-490C-AF02-2F11801EF694"><gtr:id>8AE944A8-77A6-490C-AF02-2F11801EF694</gtr:id><gtr:title>Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/346132cc73b072383cbff8aaa61b0286"><gtr:id>346132cc73b072383cbff8aaa61b0286</gtr:id><gtr:otherNames>Soler Artigas M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/12EA6DDA-7759-4557-AFC4-EAFB63855446"><gtr:id>12EA6DDA-7759-4557-AFC4-EAFB63855446</gtr:id><gtr:title>Whole exome re-sequencing implicates CCDC38 and cilia structure and function in resistance to smoking related airflow obstruction.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a94bd817e0697ab1ede1ac552afec188"><gtr:id>a94bd817e0697ab1ede1ac552afec188</gtr:id><gtr:otherNames>Wain LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1E452F97-2852-4AF7-9602-1E3FDFB9B7AA"><gtr:id>1E452F97-2852-4AF7-9602-1E3FDFB9B7AA</gtr:id><gtr:title>GSTCD and INTS12 regulation and expression in the human lung.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/50b8ae389974a10a5749dc28b02da493"><gtr:id>50b8ae389974a10a5749dc28b02da493</gtr:id><gtr:otherNames>Obeidat M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/056A6AE4-C508-4C8B-8771-8FD65D427783"><gtr:id>056A6AE4-C508-4C8B-8771-8FD65D427783</gtr:id><gtr:title>HTR4 gene structure and altered expression in the developing lung.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fe32325bae48796adae9123bd72921c5"><gtr:id>fe32325bae48796adae9123bd72921c5</gtr:id><gtr:otherNames>Hodge E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BC8D77E2-BF01-49D9-9A10-D4EEB5ACC610"><gtr:id>BC8D77E2-BF01-49D9-9A10-D4EEB5ACC610</gtr:id><gtr:title>cAMP regulation of airway smooth muscle function.</gtr:title><gtr:parentPublicationTitle>Pulmonary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8568a3bba5378fa6f462b628a756e972"><gtr:id>8568a3bba5378fa6f462b628a756e972</gtr:id><gtr:otherNames>Billington CK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1094-5539</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7F243DEF-0443-4C92-B9F6-096D383542EE"><gtr:id>7F243DEF-0443-4C92-B9F6-096D383542EE</gtr:id><gtr:title>Asthma genetics 2014: reaching for high-hanging fruit.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/87b19c37670c678f03215605a06bbde0"><gtr:id>87b19c37670c678f03215605a06bbde0</gtr:id><gtr:otherNames>Koppelman GH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8E2C226A-D1E9-4D6D-A0FA-80750ABEE145"><gtr:id>8E2C226A-D1E9-4D6D-A0FA-80750ABEE145</gtr:id><gtr:title>Copy number variation of the beta-defensin genes in europeans: no supporting evidence for association with lung function, chronic obstructive pulmonary disease or asthma.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a94bd817e0697ab1ede1ac552afec188"><gtr:id>a94bd817e0697ab1ede1ac552afec188</gtr:id><gtr:otherNames>Wain LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/ADEA100E-E10C-47C9-B233-B9F124FCD143"><gtr:id>ADEA100E-E10C-47C9-B233-B9F124FCD143</gtr:id><gtr:title>Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/346132cc73b072383cbff8aaa61b0286"><gtr:id>346132cc73b072383cbff8aaa61b0286</gtr:id><gtr:otherNames>Soler Artigas M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1000861</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>